Who
Sapna Srivastava
Director
Company insider
Files Form 4 as: Director, Nuvalent; Director, Alumis; Director, Aura Biosciences; Director, Tourmaline Bio; Director, Innoviva; Director, SQZ Biotechnologies Co; Director, Myos.
In numbers
- Trades disclosed
- 71
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 8 Feb 2013
- Last trade
- 15 Jul 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 15 Jul 2026 | NuvalentBiotechnology | SEC FORM 4 Code U | $638K5,146 at $124.00 | filing |
| 15 Jul 2026filed 15 Jul 2026 | NuvalentBiotechnology | SEC FORM 4 Code D | —3,444 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative · Biotechnology | SEC FORM 4 Code D | —68,500 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative | SEC FORM 4 Code D | —68,500 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative | SEC FORM 4 Code D | —20,000 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative | SEC FORM 4 Code D | —3,789 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative | SEC FORM 4 Code D | —4,147 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,000 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative · Biotechnology | SEC FORM 4 Code D | —3,789 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalentoption or derivative · Biotechnology | SEC FORM 4 Code D | —4,147 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalent | SEC FORM 4 Code U | $638K5,146 at $124.00 | filing |
| 15 Jul 2026filed 15 Jul 2026 | Nuvalent | SEC FORM 4 Code D | —3,444 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code A | —3,553 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ALMS Alumisoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,528 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ALMS Alumisoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,528 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ALMS AlumisBiotechnology | SEC FORM 4 Code A | —3,553 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | NuvalentBiotechnology | SEC FORM 4 Code A | —3,444 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | Nuvalent | SEC FORM 4 Code A | —3,444 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.